Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Abocain is a brand name for Bupivacaine, a long-acting local anesthetic belonging to the amide class. It functions by reversibly blocking voltage-gated sodium channels in neuronal membranes, thereby preventing the influx of sodium ions and inhibiting the generation and transmission of nerve impulses. This action leads to localized anesthesia, reducing pain and sensation in targeted areas. Abocain is primarily used for local and regional anesthesia in various medical procedures, including surgical interventions, pain management (e.g., chronic, postoperative, labor pain), and diagnostic tests. It is manufactured by Abbott Laboratories.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Abocain.